Adaptimmune Therapeutics Plc ADR (ADAPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAPY | AZN | AMGN | GILD | BMY |
| Company | Adaptimmune Therapeutics Plc ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0189 | 184.70 | 323.25 | 129.50 | 57.32 |
| High | 0.0189 | 186.36 | 332.34 | 132.34 | 58.64 |
| Low | 0.0061 | 184.19 | 320.96 | 128.34 | 57.08 |
| Latest | 0.0189 | 184.64 | 330.75 | 130.50 | 58.31 |
| Change | unch | +0.72 | +6.36 | +0.83 | +1.00 |
| % Change | unch | +0.39% | +1.96% | +0.64% | +1.74% |
| Volume | 38,400 | 1,616,800 | 3,040,400 | 5,008,900 | 7,998,800 |
| 20-Day Average Volume | 407,685 | 2,052,410 | 2,726,510 | 6,242,795 | 10,300,290 |
| Previous Close | 0.0189 | 183.92 | 324.39 | 129.67 | 57.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0105 | 185.63 | 334.91 | 131.82 | 57.51 |
| 20-Day Raw Stochastic | 80.34% | 27.86% | 33.91% | 29.01% | 54.05% |
| 20-Day Relative Strength | 54.54 | 44.49 | 43.61 | 42.84 | 51.49 |
| Weighted Alpha | -81.97 | +24.92 | +16.21 | +16.98 | +25.42 |
| Today's Opinion | 72% Sell | 24% Sell | 24% Sell | 24% Sell | 40% Buy |
| Previous Opinion | 72% Sell | 24% Sell | 40% Sell | 24% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 56% Buy | 40% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.50% since 05/12/26 | +0.05% since 05/12/26 | -1.65% since 05/12/26 | -3.29% since 05/12/26 | +3.29% since 05/12/26 |
| Low | 0.0050 on 05/13/26 | 180.55 on 05/15/26 | 320.96 on 05/19/26 | 128.34 on 05/19/26 | 55.85 on 05/13/26 |
| High | 0.0200 on 05/15/26 | 187.78 on 05/13/26 | 338.00 on 05/13/26 | 135.07 on 05/13/26 | 58.63 on 05/19/26 |
| 1-Month | |||||
| %Chg | +204.84% since 04/17/26 | -9.84% since 04/17/26 | -6.91% since 04/17/26 | -5.19% since 04/17/26 | -3.09% since 04/17/26 |
| Low | 0.0001 on 04/30/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 0.0235 on 05/12/26 | 203.37 on 04/20/26 | 356.90 on 04/20/26 | 138.54 on 04/20/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -24.40% since 02/19/26 | -11.49% since 02/19/26 | -11.92% since 02/19/26 | -13.64% since 02/19/26 | -3.30% since 02/19/26 |
| Low | 0.0001 on 04/30/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 0.0300 on 02/25/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 153.26 on 02/20/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -69.02% since 11/19/25 | +3.74% since 11/19/25 | -3.40% since 11/19/25 | +1.90% since 11/19/25 | +27.34% since 11/19/25 |
| Low | 0.0001 on 04/30/26 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.0700 on 11/20/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,009 | 285,242,976 | 175,068,416 | 160,994,368 | 117,031,088 |
| Shares Outstanding, K | 265,052 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 178,030,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -70,810,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 13,680,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -30,340,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.89 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/13/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/19/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.61 | 14.77 | 15.48 | 9.61 |